{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:58:29Z","timestamp":1768316309857,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001412"],"award-info":[{"award-number":["UL1TR001412"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Program of Emilia Romagna Region","award":["1786\/2012"],"award-info":[{"award-number":["1786\/2012"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jns.2018.10.023","type":"journal-article","created":{"date-parts":[[2018,10,28]],"date-time":"2018-10-28T17:45:44Z","timestamp":1540748744000},"page":"36-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Plasma levels of soluble NCAM in multiple sclerosis"],"prefix":"10.1016","volume":"396","author":[{"given":"Nicole","family":"Ziliotto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7799-1485","authenticated-orcid":false,"given":"Robert","family":"Zivadinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7114-4958","authenticated-orcid":false,"given":"Dejan","family":"Jakimovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Baroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Tisato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Secchiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7792-0433","authenticated-orcid":false,"given":"Niels","family":"Bergsland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa P.","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Weinstock-Guttman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5727-960X","authenticated-orcid":false,"given":"Giovanna","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jns.2018.10.023_bb0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbadis.2010.06.017","article-title":"Disruption of central nervous system barriers in multiple sclerosis","volume":"1812","author":"Alvarez","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.jns.2018.10.023_bb0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028936","article-title":"Multiple Sclerosis Pathology","volume":"8","author":"Lassmann","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.jns.2018.10.023_bb0015","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-065X.2012.01127.x","article-title":"Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models","volume":"248","author":"Takeshita","year":"2012","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.jns.2018.10.023_bb0020","first-page":"1088","article-title":"TNF-induced endothelial barrier disruption: beyond actin and Rho","volume":"112","author":"Marcos-Ramiro","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.jns.2018.10.023_bb0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.arcmed.2014.11.013","article-title":"Role of the blood-brain barrier in multiple sclerosis","volume":"45","author":"Ortiz","year":"2014","journal-title":"Arch. Med. Res."},{"issue":"2","key":"10.1016\/j.jns.2018.10.023_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jns.2004.11.001","article-title":"The role of soluble intercellular adhesion molecules in neurodegenerative disorders","volume":"228","author":"Rentzos","year":"2005","journal-title":"J. Neurol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.jns.2018.10.023_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.03.026","article-title":"Biomarkers of disease activity in multiple sclerosis","volume":"305","author":"Graber","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.jns.2018.10.023_bb0040","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2174\/1871527311312030012","article-title":"Adhesion molecules in CNS disorders: biomarker and therapeutic targets","volume":"12","author":"Ma","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"1\u20132","key":"10.1016\/j.jns.2018.10.023_bb0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jns.2014.12.035","article-title":"Immunological differences between classical phenothypes of multiple sclerosis","volume":"349","author":"Iwanowski","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2018.10.023_bb0050","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/brain\/122.12.2297","article-title":"Immunological profile of patients with primary progressive multiple sclerosis. Expression of adhesion molecules","volume":"122","author":"Duran","year":"1999","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jns.2018.10.023_bb0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s004150050313","article-title":"Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease","volume":"246","author":"McDonnell","year":"1999","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2018.10.023_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000049007","article-title":"Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement","volume":"9","author":"Baraczka","year":"2001","journal-title":"Neuroimmunomodulation"},{"issue":"1\u20132","key":"10.1016\/j.jns.2018.10.023_bb0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0165-5728(01)00469-6","article-title":"Cell surface bound and soluble adhesion molecules in CSF and blood in multiple sclerosis: correlation with MRI-measures of subclinical disease severity and activity","volume":"122","author":"Kraus","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.jns.2018.10.023_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.msard.2012.08.002","article-title":"Neural cell adhesion molecules in brain plasticity and disease","volume":"2","author":"Gnanapavan","year":"2013","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jns.2018.10.023_bb0075","doi-asserted-by":"crossref","first-page":"307175","DOI":"10.1155\/2015\/307175","article-title":"Neural plasticity in Multiple Sclerosis: The functional and molecular background","volume":"2015","author":"Ksiazek-Winiarek","year":"2015","journal-title":"Neural Plast."},{"issue":"6","key":"10.1016\/j.jns.2018.10.023_bb0080","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s100720200001","article-title":"The role of NCAM in remyelination","volume":"22","author":"Massaro","year":"2002","journal-title":"Neurol. Sci."},{"issue":"12","key":"10.1016\/j.jns.2018.10.023_bb0085","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/neu.20257","article-title":"Metalloprotease-induced ectodomain shedding of neural cell adhesion molecule (NCAM)","volume":"66","author":"Hinkle","year":"2006","journal-title":"J. Neurobiol."},{"issue":"6","key":"10.1016\/j.jns.2018.10.023_bb0090","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/jnr.20530","article-title":"Neural cell adhesion molecule function is regulated by metalloproteinase-mediated ectodomain release","volume":"80","author":"Hubschmann","year":"2005","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.jns.2018.10.023_bb0095","first-page":"397","article-title":"The neural cell adhesion molecule (NCAM) present in the cerebrospinal fluid of multiple sclerosis patients is unsialylated","volume":"13","author":"Massaro","year":"2009","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.jns.2018.10.023_bb0100","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ana.410410517","article-title":"Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b","volume":"41","author":"Calabresi","year":"1997","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2018.10.023_bb0105","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s004150170158","article-title":"Serum inflammatory markers and clinical\/MRI markers of disease progression in multiple sclerosis","volume":"248","author":"Giovannoni","year":"2001","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2018.10.023_bb0110","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00415-005-0681-7","article-title":"Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosis","volume":"252","author":"Rieckmann","year":"2005","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2018.10.023_bb0115","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14737175.2016.1181543","article-title":"Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine","volume":"16","author":"Zivadinov","year":"2016","journal-title":"Expert. Rev. Neurother."},{"issue":"1\u20132","key":"10.1016\/j.jns.2018.10.023_bb0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jns.2015.07.014","article-title":"The natural history of brain volume loss among patients with multiple sclerosis: a systematic literature review and meta-analysis","volume":"357","author":"Vollmer","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.jns.2018.10.023_bb0125","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1177\/1352458515616204","article-title":"Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients","volume":"22","author":"Bergsland","year":"2016","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.jns.2018.10.023_bb0130","first-page":"181","article-title":"Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis","volume":"87","author":"Kappus","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2018.10.023_bb0135","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2018.10.023_bb0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuroimage.2011.07.045","article-title":"Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: A case-control study","volume":"59","author":"Zivadinov","year":"2012","journal-title":"NeuroImage"},{"issue":"1","key":"10.1016\/j.jns.2018.10.023_bb0145","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nimg.2002.1040","article-title":"Accurate, robust, and automated longitudinal and cross-sectional brain change analysis","volume":"17","author":"Smith","year":"2002","journal-title":"NeuroImage"},{"issue":"3","key":"10.1016\/j.jns.2018.10.023_bb0150","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuroimage.2011.02.046","article-title":"A Bayesian model of shape and appearance for subcortical brain segmentation","volume":"56","author":"Patenaude","year":"2011","journal-title":"NeuroImage"},{"issue":"12","key":"10.1016\/j.jns.2018.10.023_bb0155","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/hbm.21402","article-title":"The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis","volume":"33","author":"Gelineau-Morel","year":"2012","journal-title":"Hum. Brain Mapp."},{"issue":"9","key":"10.1016\/j.jns.2018.10.023_bb0160","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/ene.13681","article-title":"Hemostasis Biomarkers in Multiple Sclerosis","volume":"25","author":"Ziliotto","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2018.10.023_bb0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.imlet.2017.03.011","article-title":"sNCAM as a specific marker of peripheral demyelination","volume":"185","author":"Niezgoda","year":"2017","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.jns.2018.10.023_bb0170","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0404.1995.tb06996.x","article-title":"Peripheral neuropathy in multiple sclerosis: a clinical and electrophysiologic study","volume":"91","author":"Sarova-Pinhas","year":"1995","journal-title":"Acta Neurol. Scand."},{"issue":"7","key":"10.1016\/j.jns.2018.10.023_bb0175","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1468-1331.2004.00815.x","article-title":"Pain and sensory complaints in multiple sclerosis","volume":"11","author":"Beiske","year":"2004","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2018.10.023_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193270","article-title":"Peripheral neuropathy in patients with multiple sclerosis","volume":"13","author":"Khan","year":"2018","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"10.1016\/j.jns.2018.10.023_bb0185","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jneuroim.2010.04.020","article-title":"Neural cell adhesion molecule--description of a CSF ELISA method and evidence of reduced levels in selected neurological disorders","volume":"225","author":"Gnanapavan","year":"2010","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.jns.2018.10.023_bb0190","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/jnc.12236","article-title":"Progression in multiple sclerosis is associated with low endogenous NCAM","volume":"125","author":"Gnanapavan","year":"2013","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.jns.2018.10.023_bb0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ana.410370111","article-title":"Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity","volume":"37","author":"Dore-Duffy","year":"1995","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2018.10.023_bb0200","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ana.410410307","article-title":"Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis","volume":"41","author":"Rieckmann","year":"1997","journal-title":"Ann. Neurol."},{"issue":"22 Suppl 3","key":"10.1016\/j.jns.2018.10.023_bb0205","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1212\/01.wnl.0000275236.51129.d2","article-title":"Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?","volume":"68","author":"Zivadinov","year":"2007","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18304337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18304337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T16:28:20Z","timestamp":1569342500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X18304337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":41,"alternative-id":["S0022510X18304337"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2018.10.023","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma levels of soluble NCAM in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2018.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}